Cleared Traditional

pRESET LITE Thrombectomy Device

K231539 · Phenox Limited · Neurology
Oct 2023
Decision
144d
Days
Class 2
Risk

About This 510(k) Submission

K231539 is an FDA 510(k) clearance for the pRESET LITE Thrombectomy Device, a Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (Class II — Special Controls, product code POL), submitted by Phenox Limited (Galway, IE). The FDA issued a Cleared decision on October 21, 2023, 144 days after receiving the submission on May 30, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5600.

Submission Details

510(k) Number K231539 FDA.gov
FDA Decision Cleared SESE
Date Received May 30, 2023
Decision Date October 21, 2023
Days to Decision 144 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code POL — Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5600
Definition A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature.

Similar Devices — POL Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment

All 17
pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device
K242676 · Phenox Limited · Feb 2025
Trevo NXT ProVue Retriever
K223305 · Stryker Neurovascular · Mar 2023
pRESET Thrombectomy Device
K222848 · Phenox Limited · Jan 2023
Trevo NXT ProVue Retriever
K210502 · Stryker Neurovascular · Aug 2021
Solitaire X Revascularization Device
K203358 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Mar 2021
Trevo XP ProVue Retriever and Trevo NXT? ProVue Retriever
K203219 · Stryker Neurovascular · Dec 2020